Europe Aortic Stent Grafts Market Size, Analysis, & Forecast | 2034

0
145

The europe aortic stent graft market is undergoing remarkable growth, fuelled by advancements in medical technology and a growing prevalence of aortic diseases. In 2023, the market was valued at USD 3.1 billion, with Europe holding a significant market share. As one of the key segments in vascular surgery, aortic stent grafts are used to treat aortic aneurysms and other vascular conditions, offering a minimally invasive solution for patients.

This article explores the aortic stent graft market's growth trajectory, technological innovations, key drivers, regional outlook, challenges, and the role of key players. By 2034, the market is expected to reach a value of USD 5.2 billion, expanding at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2034.

Market Overview: Aortic Stent Graft Technology

Aortic stent grafts are used in the treatment of aneurysms or other diseases affecting the aorta. These devices combine the structural support of a stent with a fabric graft to reinforce the aorta and prevent rupture. Traditionally, surgeries to treat aortic conditions involved open procedures with long recovery times and high risks. Today, advancements in stent graft material and design have led to the development of minimally invasive options that improve patient outcomes and reduce recovery time.

The global aortic stent graft market is primarily driven by the increasing demand for minimally invasive procedures, the rising number of patients diagnosed with aortic aneurysms, and technological advancements in stent graft materials, such as biocompatible and durable fabrics. Additionally, the ageing population, especially in developed regions, is contributing significantly to the growth of the market.

 

Get a Free Sample Report with Table of Contents : https://www.expertmarketresearch.com/reports/europe-aortic-stent-graft-market/requestsample


Key Drivers of Market Growth

  1. Technological Advancements in Stent Graft Design The design and material innovations in stent grafts have revolutionised the treatment of aortic aneurysms. New materials, such as nitinol (a shape-memory alloy), have enhanced the flexibility and durability of stent grafts. Furthermore, the development of more precise imaging techniques has enabled better placement and fewer complications during procedures.

  2. Rise in Aortic Aneurysm Cases Aortic aneurysms, especially abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA), are becoming increasingly common, particularly among the ageing population. According to a report by the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, which increases the demand for stent grafts as a treatment option.

  3. Minimally Invasive Procedures The preference for minimally invasive surgeries is increasing due to shorter recovery times, fewer complications, and lower costs. Aortic stent graft procedures, known as endovascular aneurysm repair (EVAR), provide a non-invasive alternative to traditional open surgery, contributing to market growth.

  4. Government Initiatives and Healthcare Expenditure Governments and healthcare organisations are focusing on reducing the mortality rate associated with aortic aneurysms. With healthcare expenditure rising in emerging markets and increasing access to medical technologies, the demand for stent grafts is expected to see significant growth in these regions.

  5. Advances in Imaging and Diagnostic Technologies The rise in diagnostic technologies such as 3D imaging, computed tomography angiography (CTA), and magnetic resonance angiography (MRA) has helped physicians accurately identify patients who would benefit from stent graft interventions. This trend is expected to boost the market for aortic stent grafts in the coming years.


Regional Market Analysis

1. Europe

Europe is one of the largest markets for aortic stent grafts, with countries like Germany, France, the UK, and Italy leading the way. The region's dominance is driven by the high prevalence of aortic diseases, well-established healthcare infrastructure, and continuous research and development in medical devices. The European Union's increasing support for advanced medical technologies further strengthens the growth prospects of the aortic stent graft market.

2. North America

The North American market, particularly the United States, is expected to experience substantial growth due to a high volume of aortic surgeries, advances in healthcare technologies, and an ageing population. The U.S. healthcare system is known for its adoption of innovative medical devices, making it a key player in the aortic stent graft market.

3. Asia-Pacific

Asia-Pacific is anticipated to be the fastest-growing market due to improving healthcare access, rising disposable income, and a growing focus on advanced medical technologies in countries such as China and India. Moreover, the increasing healthcare expenditure in these regions and rising awareness about cardiovascular diseases are expected to further propel market growth.

4. Latin America and the Middle East & Africa

The Latin American market is experiencing steady growth as a result of expanding healthcare systems and rising awareness of aortic diseases. In the Middle East and Africa, market expansion is more gradual, but significant improvements in healthcare infrastructure and medical tourism are supporting demand for aortic stent grafts.


Key Challenges

  1. High Cost of Stent Grafts Aortic stent grafts are costly, and this can limit access in emerging markets. The high cost of treatment can deter both patients and healthcare providers from adopting these devices, thus acting as a restraint on market growth.

  2. Post-Surgical Complications Although minimally invasive, stent graft procedures are not without risk. Potential complications such as endoleaks, graft migration, and infection can occur after surgery, which may discourage some patients from opting for stent graft treatments.

  3. Lack of Skilled Professionals The successful implementation of endovascular aneurysm repair (EVAR) requires a highly skilled medical workforce. In some regions, the shortage of adequately trained vascular surgeons and interventional radiologists may restrict market growth.


Market Trends

  1. Personalisation of Stent Graft Devices Companies are focusing on developing customisable stent graft devices that can be tailored to the specific needs of patients. These advancements include bespoke stent grafts for complex aortic anatomies.

  2. Combination with Drug-Eluting Technologies Drug-eluting stent grafts, which deliver therapeutic drugs to the aorta to prevent restenosis or re-rupture, are gaining traction. These devices could potentially reduce the risk of complications and improve patient outcomes.

  3. Increased Use of 3D Printing 3D printing is being used to create patient-specific models and devices, improving the accuracy of stent graft placements and reducing the risk of complications. This innovation is expected to improve surgical outcomes and reduce the time for recovery.


Key Players in the Aortic Stent Graft Market

Several key players dominate the global aortic stent graft market. These companies are at the forefront of technological advancements, market expansion, and strategic collaborations to improve their product portfolios.

1. Medtronic

Medtronic is a leader in the aortic stent graft market, with its flagship product, the Endurant™ Stent Graft System, widely used in the treatment of abdominal and thoracic aortic aneurysms. The company has a robust global presence and continues to innovate in the field of endovascular surgery.

2. Johnson & Johnson

Through its subsidiary, Cordis, Johnson & Johnson is another key player in the aortic stent graft market. The company offers a variety of stent grafts, including the Absolute™ Pro Self-Expanding Stent System, which is commonly used in the treatment of complex vascular diseases.

3. Cook Medical

Cook Medical is renowned for its strong presence in the aortic stent graft market. The company's Zenith® Stent Graft platform is widely recognised for its precision and reliability, offering solutions for both abdominal and thoracic aneurysms.

4. Boston Scientific

Boston Scientific offers a comprehensive portfolio of stent grafts and related products. The company's Valiant™ and Lotus™ systems are designed for the treatment of thoracic aortic aneurysms and are backed by the latest advancements in material science and medical technology.

5. Terumo Corporation

Terumo, a Japanese medical technology company, is making significant strides in the aortic stent graft market. The company's products are known for their durability and performance in treating complex vascular diseases.


FAQs

1. What is an aortic stent graft?

An aortic stent graft is a medical device used to treat aortic aneurysms. It combines a stent, which provides structural support, with a graft, which reinforces the aorta.

2. What are the main factors driving the growth of the aortic stent graft market?

Key drivers include advancements in stent graft technology, increasing aortic disease prevalence, and the growing demand for minimally invasive procedures.

3. Which region holds the largest share of the aortic stent graft market?

Europe holds a significant share of the global aortic stent graft market, followed closely by North America.

4. What are the risks associated with aortic stent graft procedures?

Potential risks include endoleaks, graft migration, infection, and complications during surgery. However, these risks are lower compared to traditional open surgeries.

5. Who are the key players in the global aortic stent graft market?

Key players include Medtronic, Johnson & Johnson, Cook Medical, Boston Scientific, and Terumo Corporation.

 

Media Contact

Company Name: Claight Corporation
Contact Person: Stephen Grand, Corporate Sales Specialist — U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1–415–325–5166 | +44–702–402–5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com
Aus Site: https://www.expertmarketresearch.com.au